ReviewNature reviews. Urology2023

Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment.

Kyle Nolla et al.PubMed ↗Publisher ↗

No numbers read from the abstract.